Färbom Patrik, Wahlstrand Björn, Almgren Peter, Skrtic Stanko, Lanke Jan, Weiss Lars, Kjeldsen Sverre, Hedner Thomas, Melander Olle
Department of Clinical Sciences, Clinical Research Center, Entrance 72, Bldg 91, Fl 12, Malmö University Hospital, SE-205 02 Malmö, Sweden.
Hypertension. 2008 Jul;52(1):115-22. doi: 10.1161/HYPERTENSIONAHA.107.109264. Epub 2008 May 26.
We investigated whether renal function and microalbuminuria are independent predictors and whether any interaction exists between them, regarding future cardiovascular disease in hypertensive patients (n=10 881) followed for 4.5 years. The primary end points (PEs) were fatal and nonfatal myocardial infarction and stroke and other cardiovascular deaths. Creatinine and glomerular filtration rate (GFR), estimated using the formulas of the Modification of Diet in Renal Disease study group and Cockroft and Gault and in a subsample (n=4929) of microalbuminuria and interaction terms of microalbuminuria and renal function, were related to the risk of the PE using Cox proportional hazards model after full adjustment. Increased creatinine (P<0.001), decreased GFR from Cockroft and Gault (P=0.001), and decreased GFR from the Modification of Diet in Renal Disease study group (P=0.001) were all independent risk factors for the PE. Stepwise exclusion of patients with the poorest renal function excluded the possibility that the relationship between decreasing renal function and the PE was driven only by patients with severely impaired renal function. Microalbuminuria and all 3 of the indices of renal function predicted the PE independent of each other. There was a significant interaction between microalbuminuria and GFR from Cockroft and Gault (P=0.040) in prediction of the PE. Both renal function and microalbuminuria add independent prognostic information regarding cardiovascular risk in hypertensive patients. The cardiovascular risk associated with microalbuminuria increases with a decline in GFR, as demonstrated by a significant interaction between microalbuminuria and GFR from Cockroft and Gault. Because estimation of the total cardiovascular risk is essential for the aggressiveness of risk factor interventions, simultaneous inclusion of GFR and microalbuminuria in global cardiovascular risk assessment is essential.
我们对10881例高血压患者进行了4.5年的随访,研究肾功能和微量白蛋白尿是否为未来心血管疾病的独立预测因素,以及它们之间是否存在相互作用。主要终点(PEs)为致命性和非致命性心肌梗死、中风及其他心血管死亡。使用肾病饮食改良研究组、Cockroft和Gault公式估算肌酐和肾小球滤过率(GFR),并在微量白蛋白尿及微量白蛋白尿与肾功能交互项的一个子样本(n = 4929)中,采用Cox比例风险模型在充分校正后分析其与PE风险的关系。肌酐升高(P < 0.001)、Cockroft和Gault公式估算的GFR降低(P = 0.001)以及肾病饮食改良研究组估算的GFR降低(P = 0.001)均为PE的独立危险因素。逐步排除肾功能最差的患者后,排除了肾功能下降与PE之间的关系仅由肾功能严重受损患者驱动的可能性。微量白蛋白尿和所有3项肾功能指标相互独立地预测了PE。在预测PE方面,微量白蛋白尿与Cockroft和Gault公式估算的GFR之间存在显著交互作用(P = 0.040)。肾功能和微量白蛋白尿均为高血压患者心血管风险提供独立的预后信息。微量白蛋白尿相关的心血管风险随GFR下降而增加,微量白蛋白尿与Cockroft和Gault公式估算的GFR之间的显著交互作用证明了这一点。由于估计总体心血管风险对于危险因素干预的积极程度至关重要,因此在全球心血管风险评估中同时纳入GFR和微量白蛋白尿至关重要。